Brief: Aptorum Group Ltd Announces Development Of Two Preclinical Drug Candidates Which Target Obesity And Neuroblastoma, Respectively

Aptorum

09/09/2019 12:11

Sept 9 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP LTD -  ANNOUNCES DEVELOPMENT OF TWO
PRECLINICAL
DRUG CANDIDATES WHICH TARGET OBESITY AND NEUROBLASTOMA,
RESPECTIVELY
    * APTORUM GROUP LTD - CLS-1 IS UNDERGOING LEAD OPTIMIZATION
AND IS
EXPECTED TO PROGRESS INTO IND ENABLING STAGE IN 2020

Source text for Eikon:  ID:nBw90MZwVa 
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))